Skin, the final frontier

International Journal of Pharmaceutics

Volumn 224, Issue 1-2, 2001, Pages 1-18

  Hadgraft, Jonathan ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; CARBENE; CERAMIDE; CORTICOSTEROID DERIVATIVE; CYANOPHENOL; DIETHYLENE GLYCOL MONOETHYL ETHER; FLURBIPROFEN; GLYCERYL TRINITRATE; HYDROCORTISONE; HYDROCORTISONE ACETATE; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; INSECT REPELLENT; LAUROCAPRAM; LIDOCAINE; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLEIC ACID; PARACETAMOL; PHENOL DERIVATIVE; PHLORETIN; PIROXICAM; PRODRUG; PYRROLE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

DRUG ABSORPTION; DRUG DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; HYDROGEN BOND; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; SKIN PENETRATION; STEADY STATE; STRATUM CORNEUM;

EID: 0035859979     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00731-1     Document Type: Note

References (80)

1. Percutaneous absorption: Transport in the dermis
2. Percutaneous absorption: In vivo experiments
3. Percutaneous absorption: Theoretical description
4. Liposome-mediated gene-transfer and expression via the skin
5. In vivo microdialysis estimation of histamine in human skin
6. Fluorescence spectroscopic evaluation of the fluidity gradient in stratum-corneum lipids
7. The influence of urea on percutaneous-absorption
8. In-vivo optothermal measurement of epidermal thickness
9. Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes
10. 2 transport through human skin in vitro
11. Structure-dependent enhancement by azones of peptide (Dgavp) transport through human stratum-corneum
12. Examination of the effect of ethanol on human stratum-corneum in vivo using infrared-spectroscopy
13. Transdermal drug carriers-basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides
14. Enhancement of percutaneous absorption by the use of volatile: Nonvolatile systems as vehicles
15. Maintenance of skin viability during in vitro percutaneous absorption-metabolism studies
16. Probing the effect of vehicles on topical delivery: Understanding the basic relationship between solvent and solute penetration kinetics using silicone membranes
17. Effect of supersaturation on membrane transport. 1. Hydrocortisone acetate
18. Modelling the transdermal delivery of non-steroidal anti-inflammatory agents
19. 14C cortisol in man
20. Transdermal penetration enhancers: Applications, limitations, and potential
21. Correlation at fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes
22. An electron spin resonance study of skin penetration enhancers
23. Physicochemical interpretation of the pharmacokinetics of percutaneous-absorption
24. Kinetic-analysis of transdermal nitroglycerin delivery
25. Pharmacokinetic interpretation of the plasma-levels of clonidine following transdermal delivery
26. Interpretation and prediction of the kinetics of transdermal drug delivery-estradiol, hyoscine and timolol
27. A pharmacokinetic model for percutaneous-absorption
28. Review article percutaneous absorption
29. PH, pK(a) and dermal delivery
30. The effect of thermodynamic activity on the percutaneous absorption of methyl nicotinate from water glycerol mixtures
31. In vivo-in vitro comparisons in the transdermal delivery of nitroglycerin
32. Mechanisms of action of skin penetration enhancers retarders - Azone and Analogs
33. The selection of non-steroidal anti-inflammatory agents for dermal delivery
34. Drug penetration as studied by noninvasive methods: Fourier transform infrared-attenuated total reflection, Fourier transform infrared, and ultraviolet photoacoustic spectroscopy
35. Azone(R) induced fluidity in human stratum corneum. A Fourier transform infrared spectroscopy investigation using the analogue
36. The relative effect of azone(R) and transcutol(R) on permeant diffusivity and solubility in human stratum-corneum
37. Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base
38. Membrane penetration enhancement of ibuprofen using supersaturation
39. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle
40. Effects of penetration enhancers on percutaneous absorption of nifedipine. Comparison between Deet and Azone
41. Mixed monolayers of dipalmitoylphosphatidylcholine with Azone or oleic acid at the air-water interface
42. Mixed monolayer studies of DPPC with N-aklyl-aza-cycloheptanones at the air-water interface
43. The influence of vehicles on the local bioavailability of betamethasone-17-benzoate from solution-type and suspension-type ointments
44. Percutaneous absorption of alkanoic acids II: Application of regular solution theory
45. Skin metabolism of topically applied compounds
46. Phonophoresis of methyl nicotinate - A preliminary-study to elucidate the mechanism of action
47. Drug permeation through human skin: Theory and in vitro experimental measurement
48. Enhanced skin permeation of sex hormones with novel topical spray vehicles
49. In situ precipitation: A novel cyotchemical technique for visualization of permeability pathways in mammalian stratum corneum
50. Percutaneous penetration of methyl phosphonate antisense oligonucleotides
51. Evidence that oleic acid exists in a separate phase within stratum corneum lipids
52. Effect of supersaturation on membrane transport: 2. Piroxicam
53. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique
54. Diffusion of flurbiprofen across human stratum corneum using synergistic methods of enhancement
55. The influence of stratum-corneum morphology on water permeability
56. Predicting skin permeability
57. Epidermal permeability-penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge
58. Epidermal permeability-penetrant structure relationships. 3. The effect of hydrogen-bonding interactions and molecular-size on diffusion across the stratum-corneum
59. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate
60. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers
61. Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in-vitro
62. Epidermal permeability: Penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum
63. Epidermal permeability penetrant structure relationships.1. An analysis of methods of predicting penetration of monofunctional solutes from aqueous solutions
64. Gas propulsion of microprojectiles for the transdermal delivery of powder form drugs
65. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: Relevance to bioavailability and bioequivalence
66. Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin
67. Influence of solvents on paraben permeation through idealized skin model membranes
68. Effect of phloretin on the percutaneous absorption of lignocaine across human skin
69. Solubility and partitioning. 4. Aqueous solubility and octanol-water partition-coefficients of liquid non-electrolytes
70. Factors affecting transdermal delivery of metoprolol by electroporation
71. Small angle neutron scattering (SANS) studies on DPPC/Azone® multilamellar systems
72. Computer simulation of penetrant concentration-depth profiles in the stratum corneum
73. Neutrons, surfaces, and skin
74. Optothermal measurement of water distribution within the stratum corneum
75. Skin permeability of various non-steroidal anti-inflammatory drugs in man